Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 3NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

bicalutamide 23Radiotherapy 21Goserelin 21Docetaxel 19Flutamide 17Leuprolide 16Prednisone 11Radiotherapy, Conformal 10Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Triptorelin Pamoate 8Buserelin 8Estramustine 7Androgen Antagonists 7Brachytherapy 6luprolide acetate gel depot 5enzalutamide 5Paclitaxel 5nilutamide 4darolutamide 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Radiation 4Mitoxantrone 4Carboplatin 4orteronel 3apalutamide 3Selenium 3Orchiectomy 3Magnetic Resonance Spectroscopy 3Iodine-125 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Prostatic Neoplasms × Cyproterone Acetate × Clear all
NCT00003653 2021-06-23

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
1,386 enrolled
Genitourinary

Prostatic Neoplasms

NCT00849082 2012-07-11

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡